{
    "case_number": "CAC-UDRP-104829",
    "time_of_filling": "2022-09-07 09:40:29",
    "domain_names": [
        "buymicardis.xyz"
    ],
    "case_administrator": "Denisa Bilík (CAC) (Case admin)",
    "complainant": [
        "BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG"
    ],
    "complainant_representative": "NAMESHIELD S.A.S.",
    "respondent": [
        "Stacey  McGrath "
    ],
    "respondent_representative": null,
    "factual_background": "<p>The Complainant is a German family-owned pharmaceutical group of companies with roots going back to 1885, when it was founded by Albert Boehringer in Ingelheim am Rhein. Today, the Complainant is one of the world's leading research-driven pharmaceutical companies with about 140 affiliate companies world-wide and about 52,000 employees.&nbsp; The three business areas of Boehringer Ingelheim are human pharmaceuticals, animal health and bio pharmaceuticals. In 2021, net sales of the Boehringer Ingelheim group amounted to about EUR 20.6 billion. MICARDIS is a medicine produced by the Complainant and prescribed for the treatment of hypertension.&nbsp;&nbsp;<\/p>\n<p>The Respondent registered the disputed domain name &lt;buymicardis.xyz&gt; on 15 August 2022.&nbsp; As at the date of the amended complaint, the disputed domain name resolved to a parking page with commercial links.&nbsp; As at the date of this decision, the disputed domain name resolves to an error page without active content.&nbsp;<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>No administratively compliant Response has been filed.&nbsp;<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trade mark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Gregor Kleinknecht LLM MCIArb"
    ],
    "date_of_panel_decision": "2022-10-14 00:00:00",
    "informal_english_translation": "<p>The Complainant owns a portfolio of trade marks consisting of the name MICARDIS, including the international trade mark MICARDIS, registration number 523578, first registered on 18 May 1988 in international class 5; and the international trade mark MICARDIS, registration number 691750, first registered on 13 March 1998 in international class 5.&nbsp; These trade mark registrations predate the registration of the disputed domain name.<\/p>\n<p>Furthermore, the Complainant owns multiple domain names consisting of the word MICARDIS, including the domain name &lt;micardis.com&gt;, registered on 1 April 1999, which is connected to the official Boehringer Ingelheim Micardis product website for international healthcare professionals.&nbsp;<\/p>",
    "decision_domains": {
        "buymicardis.xyz": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}